OverviewSuggest Edit

Integra LifeSciences is an integrated medical device company providing solutions used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Its products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. The company serves hospitals, surgery centers, and alternate care sites, including physician and dental offices.
TypePublic
HQPrinceton, NJ, US
Websiteintegralife.com
Employee Ratings3.3
Overall CultureB

Latest Updates

Employees (est.) (Dec 2019)4,000(-11%)
Job Openings222
Revenue (FY, 2020)$1.4 B(-9%)
Share Price (Sept 2021)$69.9
Cybersecurity ratingCMore

Key People/Management at Integra LifeSciences

Peter Arduini

Peter Arduini

President & Chief Executive Officer
Kenneth Burhop

Kenneth Burhop

Corporate Vice President, Chief Scientific Officer
Andrea Caruso

Andrea Caruso

Corporate Vice President, Business Development
Glenn G. Coleman

Glenn G. Coleman

Executive Vice President & Chief Operating Officer
William Compton

William Compton

Corporate Vice President & Chief Information Officer
Carrie Anderson

Carrie Anderson

Executive Vice President & Chief Financial Officer
Show more

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Princeton, Memphis, Clayton, Shanghai and in 1 other location
Princeton, NJ, US (HQ)
1100 Campus Rd
Memphis, TN, US
7740 Trinity Rd #107, Cordova
Clayton, AU
3/24-30 Winterton Rd
Shanghai, CN
Unit 307, B Tower, SOHO Fuxing Plaza, Danshui Road, Huangpu District
Minato City, JP
6-chōme-19-33 Akasaka
Show all (5)

Integra LifeSciences Financials and Metrics

Integra LifeSciences Revenue

Embed Graph
View revenue for all periods
Integra LifeSciences's revenue was reported to be $1.37 b in FY, 2020
USD

Revenue (Q2, 2021)

390.0m

Gross profit (Q2, 2021)

238.7m

Gross profit margin (Q2, 2021), %

61.2%

Net income (Q2, 2021)

35.1m

EBIT (Q2, 2021)

51.9m

Market capitalization (14-Sept-2021)

5.9b

Closing stock price (14-Sept-2021)

69.9

Cash (30-Jun-2021)

397.4m

EV

6.4b
Integra LifeSciences's current market capitalization is $5.9 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

1.2b1.5b1.5b1.4b

Revenue growth, %

24%3%

Cost of goods sold

435.5m571.5m564.7m520.8m

Gross profit

752.7m900.9m952.9m851.0m
Quarterly
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

174.9m138.8m198.9m470.2m

Accounts Receivable

251.8m265.7m275.3m225.5m

Prepaid Expenses

99.1m90.2m67.9m69.3m

Inventories

296.3m280.3m316.1m310.1m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

64.7m60.8m50.2m133.9m

Depreciation and Amortization

88.9m110.7m109.5m116.0m

Inventories

99.0k8.3m(43.3m)(48.3m)

Accounts Payable

95.3m3.6m14.7m(57.5m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Net Income

11.0m22.4m35.7m32.8m62.5m34.9m9.2m8.8m41.1m45.4m80.5m

Depreciation and Amortization

27.1m54.0m83.1m27.1m54.0m81.6m29.2m58.8m89.9m29.2m8.7m

Inventories

1.3m(3.6m)(3.4m)(12.0m)(21.6m)(30.6m)(26.2m)(47.0m)(45.5m)(2.3m)2.9m

Accounts Payable

3.0m(3.4m)9.4m5.4m16.4m366.0k(40.2m)(88.7m)(67.2m)14.4m27.3m
USDFY, 2017

Revenue/Employee

270.1k

Debt/Equity

1.9 x

Debt/Assets

0.6 x

Financial Leverage

3.3 x
Show all financial metrics

Integra LifeSciences Revenue Breakdown

Embed Graph

Integra LifeSciences revenue breakdown by business segment: 65.6% from Codman Specialty Surgical and 34.4% from Orthopedics and Tissue Technologies

Integra LifeSciences revenue breakdown by geographic segment: 71.0% from United States, 13.0% from Europe, 10.4% from Asia Pacific and 5.6% from Rest of World

Integra LifeSciences Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

Integra LifeSciences Online and Social Media Presence

Embed Graph

Integra LifeSciences Company Culture

  • Overall Culture

    B

    71/100

  • CEO Rating

    B

    70/100

  • Compensation

    A

    83/100

  • Diversity

    F

    41/100

Learn more on Comparably

Integra LifeSciences News and Updates

Integra LifeSciences Announces Positive Clinical Outcomes for PriMatrix® Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers

Data Shows a Single Application of PriMatrix Closed More Wounds Than Standard of Care Alone Data Shows a Single Application of PriMatrix Closed More Wounds Than Standard of Care Alone

Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction

Contract awarded for products that bring improvement to healthcare industry Contract awarded for products that bring improvement to healthcare industry

Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021

PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2021 financial results on Wednesday, July 28, 2021 prior to market open. In conjunction with the earnings release, I…

Integra LifeSciences Announces CEO Succession Plan

Peter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor Peter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor

Integra LifeSciences Hosts Virtual Investor Day

PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m. ET, today May 20, 2021.

Integra LifeSciences to Host Virtual Investor Day on May 20, 2021

PRINCETON, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m., U.S. eastern time on May 20, 2021.
Show more

Integra LifeSciences Frequently Asked Questions

  • Who are Integra LifeSciences key executives?

    Integra LifeSciences's key executives are Peter Arduini, Kenneth Burhop and Andrea Caruso.

  • How many employees does Integra LifeSciences have?

    Integra LifeSciences has 4,000 employees.

  • What is Integra LifeSciences revenue?

    Latest Integra LifeSciences annual revenue is $1.4 b.

  • What is Integra LifeSciences revenue per employee?

    Latest Integra LifeSciences revenue per employee is $343 k.

  • Who are Integra LifeSciences competitors?

    Competitors of Integra LifeSciences include Cook Medical, Wright Medical and NuVasive.

  • Where is Integra LifeSciences headquarters?

    Integra LifeSciences headquarters is located at 1100 Campus Rd, Princeton.

  • Where are Integra LifeSciences offices?

    Integra LifeSciences has offices in Princeton, Memphis, Clayton, Shanghai and in 1 other location.

  • How many offices does Integra LifeSciences have?

    Integra LifeSciences has 5 offices.